ANGIOTECH PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Four
ANGIOTECH PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $29.50 million as of 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2013-03-28
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $29.50M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Four |
|---|---|
| 2012-12-31 | $29.50M 10-K · filed 2013-03-28 |